MEDNAX, Inc., provides neonatal, maternal-fetal, pediatric cardiology, and other pediatric subspecialties in the United States and Puerto Rico. The company is headquartered in Sunrise, Florida.
| Revenue (TTM) | $1.93B |
| Gross Profit (TTM) | $504.02M |
| EBITDA | $261.57M |
| Operating Margin | 9.78% |
| Return on Equity | 20.90% |
| Return on Assets | 7.35% |
| Revenue/Share (TTM) | $23.22 |
| Book Value | $10.96 |
| Price-to-Book | 1.99 |
| Price-to-Sales (TTM) | 0.90 |
| EV/Revenue | 1.06 |
| EV/EBITDA | 7.18 |
| Quarterly Earnings Growth (YoY) | 50.00% |
| Quarterly Revenue Growth (YoY) | 3.90% |
| Shares Outstanding | $82.12M |
| Float | $79.05M |
| % Insiders | 2.35% |
| % Institutions | 105.51% |
Volatility is currently contracting